PeptideDB

7-Chloro-4-(piperazin-1-yl)quinoline 837-52-5

7-Chloro-4-(piperazin-1-yl)quinoline 837-52-5

CAS No.: 837-52-5

7-Chloro-4-(piperazin-1-yl)quinolone is an important scaffold in active molecular chemistry. 7-Chloro-4-(piperazin-1-yl)
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

7-Chloro-4-(piperazin-1-yl)quinolone is an important scaffold in active molecular chemistry. 7-Chloro-4-(piperazin-1-yl)quinolone is a potent sirtuin inhibitor that also inhibits serotonin uptake (IC50 of 50 μM). 7-Chloro-4-(piperazin-1-yl)quinolone displays antimalarial activity against Plasmodium falciparum D10 and K1 strains with IC50 of 1.18 μM and 0.97 μM, respectively.

Physicochemical Properties


Molecular Formula C13H14CLN3
Molecular Weight 247.72
Exact Mass 247.088
CAS # 837-52-5
PubChem CID 738389
Appearance White to yellow solid powder
Density 1.257 g/cm3
Boiling Point 433.5ºC at 760 mmHg
Melting Point 113-116ºC
Flash Point 216ºC
Index of Refraction 1.636
LogP 2.691
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 1
Heavy Atom Count 17
Complexity 255
Defined Atom Stereocenter Count 0
InChi Key DNXNPMDUDGUXOB-UHFFFAOYSA-N
InChi Code

InChI=1S/C13H14ClN3/c14-10-1-2-11-12(9-10)16-4-3-13(11)17-7-5-15-6-8-17/h1-4,9,15H,5-8H2
Chemical Name

7-chloro-4-piperazin-1-ylquinoline
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Plasmodium
References

[1]. Structural and biological survey of 7-chloro-4-(piperazin-1-yl)quinoline and its derivatives. Drug Dev Res. 2020 Nov;81(7):786-802.


Solubility Data


Solubility (In Vitro) DMSO : 16.67 mg/mL (67.29 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 1.67 mg/mL (6.74 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 16.7 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 1.67 mg/mL (6.74 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 16.7 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 1.67 mg/mL (6.74 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 16.7 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.0368 mL 20.1841 mL 40.3682 mL
5 mM 0.8074 mL 4.0368 mL 8.0736 mL
10 mM 0.4037 mL 2.0184 mL 4.0368 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.